The use of allogeneic T lymphocytes and bacterial lipopolysaccharide to induce immune responses to monovalent haptens in vitro.
D000818:Animals; D000917:Antibody Formation; D000918:Antibody Specificity; D000921:Antibody-Producing Cells; D000961:Antilymphocyte Serum; D001345:Autoradiography; D002478:Cells, Cultured; D003165:Complement System Proteins; D004140:Dinitrophenols / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D005997:Glycerylphosphorylcholine / Q000276:immunology; D006241:Haptens; D006462:Hemolytic Plaque Technique; D006736:Horses / Q000276:immunology; D007519:Isoantigens; D008070:Lipopolysaccharides / Q000276:immunology*; D008212:Lymphocyte Depletion; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009194:Myeloma Proteins; D009596:Nitrophenols / Q000276:immunology; D011135:Polysaccharides, Bacterial; D011828:Radiation Chimera; D012709:Serum Albumin; D013154:Spleen / Q000166:cytology; D013296:Streptococcus pneumoniae / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D013936:Thymidine / Q000378:metabolism; D013950:Thymus Gland / Q000002:abnormalities; D014316:Tritium
D000961:Antilymphocyte Serum; D004140:Dinitrophenols; D006241:Haptens; D007519:Isoantigens; D008070:Lipopolysaccharides; D009194:Myeloma Proteins; D009596:Nitrophenols; D011135:Polysaccharides, Bacterial; D012709:Serum Albumin; D014316:Tritium; D005997:Glycerylphosphorylcholine; D003165:Complement System Proteins; D013936:Thymidine